New short blogpost!
I wrote a round up of cancer research news from ASCO2026:
- Daraxonrasib, the breakthrough pancreatic cancer drug
- Big 7-year results of lorlatinib for ALK+ lung cancers
– Talazoparib, a prostate cancer drug that cut the risk of progression by half
and much more. Read here:
